Expert Illustrations & Commentaries™: Visualizing the Role of Nitric Oxide in Glaucoma
September 21, 2021
September 21, 2022
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Physicians’ Education Resource®, LLC.
This activity is supported by an educational grant from Bausch + Lomb.
- Optometrists — 1.0 Contact Hours
All other health care professionals completing this course will be issued a statement of participation. For those seeking CME/CE credit on this topic, please click here: https://learning.freecme.com/a/38121PAxBGvP for this program.
This educational activity is directed toward ophthalmologists and optometrists, including those in residency and fellowship training. Other clinicians involved in the care of patients with a diagnosis of glaucoma are also invited to participate.
This Expert Illustrations and Commentaries™ is a video-based program in which 2 experts share their insights and experience in the diagnosis and treatment of glaucoma. In this activity, faculty members focus on the pathophysiology of glaucoma and the emerging benefits of using nitric oxide (NO) to target the conventional outflow pathway. Their discussion is enriched with the use of video animations to illustrate the pathophysiology of glaucoma and the mechanisms of action for nitric oxide–donating agents. The use of these animated segments helps to make somewhat complicated subject matter more easily understood. This unique format is designed to help clinicians assimilate newer treatments into practice by gaining a better understanding of how they address the underlying pathophysiology.
Upon successful completion of this activity, you should be better prepared to:
- Characterize the structural and functional changes that occur in aqueous humor outflow routes in open-angle glaucoma (OAG)
- Explain the differences in mechanism of action of NO-donor therapy and other classes of topical glaucoma treatments
- Compare and contrast efficacy and safety data from topical glaucoma therapy classes
- Apply patient- and treatment-related factors for optimal management of OAG with topical therapies
Jason Bacharach, MD
North Bay Eye Associates, Inc.
Sonoma County, CA
Co-Director, Glaucoma Division
California Pacific Medical Center
San Francisco, CA
Inder Paul Singh, MD, MPH
The Eye Centers of Racine and Kenosha, LLC
Racine and Kenosha, WI
The Chicago Medical School
North Chicago, IL
Optometrist Continuing Education
This activity, COPE Activity Number 122390, is accredited by COPE for continuing education for optometrists.
Disclosures of Conflicts of Interest
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.
Jason Bacharach, MD
- Grant/Research Support: NiCox; Consultant: Bausch + Lomb
- Speaker’s Bureau: Bausch + Lomb
Inder Paul Singh, MD, MPH
- Grant/Research Support: Glaxos, iSTAR Medical, Ivantis, Nova Eye
- Consultant: Bausch + Lomb, Allergan, Ivantis, Ace Vision, Glaxos, Visus Therapeutics, Nova Eye, Sight Sciences
- Speaker’s Bureau: Bausch + Lomb, Allergan, Ivantis, Glaxos, New World Medical, Sun Pharma, Sight Sciences
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Instructions for Participation and Credit
- Complete the activity (including pre- and post-activity assessments).
- Answer the evaluation questions.
- Request credit using the drop-down menu.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.